US 9814706
Hydrobromide salt of pridopidine
granted A61KA61K31/451A61P
Quick answer
US patent 9814706 (Hydrobromide salt of pridopidine) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/451, A61P, A61P25/00, A61P25/14